Servier

Servier is a privately-owned international pharmaceutical company governed by a non-profit organization. Our independence allows the freedom to pursue our vocation: our commitment to therapeutic progress to serve patient needs.We invest close to 70% of our R&D budget in oncology, with a view to becoming a focused and innovative player in rare cancer treatments.A healthy environment is indispensable for good health. That is why at Servier, we endeavor to address climate change and the degradation of our environment. Our corporate social responsibility applies first and foremost to our people